ICMR-NICED proposes research on oral COVID vaccine

Kolkata-based ICMR-NICED has submitted a proposal to the Department of Biotechnology under the Union Ministry of Science and Technology for research on an oral COVID vaccine, a senior official of the institute said on Monday.

The proposed research project will be done in collaboration with a German firm and it has been shortlisted for presentation, she said.

“We have submitted a proposal for research on an oral vaccine. It will be carried out in collaboration with a German firm. Work can be started once it gets selected and funded,” ICMR-NICED Director Shanta Dutta said.

She said it will take around 5-6 years to develop the oral vaccine in a laboratory.

Once the oral vaccine is developed, it will first be tested on animals as is done for all vaccines, Dutta said.

“All stages of developing a vaccine, and phases of clinical trials for safety and immunogenicity will be followed in this case too and the vaccine will be first tested on animals.

“The entire process will take at least five to six years and we can expect the oral vaccine in the market only after that,” she added.

  • Related Posts

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    New Delhi: Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the pharmaceutical industry. “Had…

    Senores Pharma to Buy Two Teva ANDAs

    Mumbai, August 14, 2025 — Senores Pharmaceuticals will acquire two abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA. The deal is Senores’ third US move in six months, underscoring…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Senores Pharma to Buy Two Teva ANDAs

    Senores Pharma to Buy Two Teva ANDAs

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lilly launches Mounjaro KwikPen in India

    Lilly launches Mounjaro KwikPen in India